Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Cescon

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Cancer Research|February 19, 2021
Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced <i>N</i>-glycosylation Abundance and BranchingRosemary Yu, Joseph Longo, Jenna E van Leeuwen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Genetic polymorphisms and head and neck cancer outcomes: a reviewJessica Hopkins, David W Cescon, Darren Tse, et al.
Advanced Healthcare Materials|October 12, 2021
Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer TherapiesElisabeth Prince, Sina Kheiri, Yihe Wang, et al.
Breast (Edinburgh, Scotland)|June 9, 2026
New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practiceHope S Rugo, Giuseppe Curigliano, David W Cescon, et al.
Science Advances|July 30, 2025
Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arraysIlya Yakavets, Sina Kheiri, Jennifer Cruickshank, et al.
Iscience|January 7, 2026
Simulating cell-free chromatin using preclinical cancer models for liquid biopsy applicationsSasha C Main, Steven D De Michino, Lucas Penny, et al.
Future Oncology (London, England)|August 1, 2023
TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancerRebecca A Dent, David W Cescon, Thomas Bachelot, et al.
NPJ Breast Cancer|June 23, 2020
Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective studyMitchell J Elliott, Marguerite Ennis, Kathleen I Pritchard, et al.
Cancer Cell|July 22, 2014
Functional characterization of CFI-400945, a Polo-like kinase 4 inhibitor, as a potential anticancer agentJacqueline M Mason, Dan Chi-Chia Lin, Xin Wei, et al.
Cancer Research|November 21, 2023
Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic LethalityPeter Lin, Corey Lourenco, Jennifer Cruickshank, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Cancer Research|February 19, 2021
Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced <i>N</i>-glycosylation Abundance and BranchingRosemary Yu, Joseph Longo, Jenna E van Leeuwen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2008
Genetic polymorphisms and head and neck cancer outcomes: a reviewJessica Hopkins, David W Cescon, Darren Tse, et al.
Advanced Healthcare Materials|October 12, 2021
Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer TherapiesElisabeth Prince, Sina Kheiri, Yihe Wang, et al.
Breast (Edinburgh, Scotland)|June 9, 2026
New perspectives on endocrine therapy suitability for hormone receptor-positive metastatic breast cancer in clinical practiceHope S Rugo, Giuseppe Curigliano, David W Cescon, et al.
Science Advances|July 30, 2025
Machine learning-assisted exploration of multidrug-drug administration regimens for organoid arraysIlya Yakavets, Sina Kheiri, Jennifer Cruickshank, et al.
Iscience|January 7, 2026
Simulating cell-free chromatin using preclinical cancer models for liquid biopsy applicationsSasha C Main, Steven D De Michino, Lucas Penny, et al.
Future Oncology (London, England)|August 1, 2023
TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancerRebecca A Dent, David W Cescon, Thomas Bachelot, et al.
NPJ Breast Cancer|June 23, 2020
Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective studyMitchell J Elliott, Marguerite Ennis, Kathleen I Pritchard, et al.
Cancer Cell|July 22, 2014
Functional characterization of CFI-400945, a Polo-like kinase 4 inhibitor, as a potential anticancer agentJacqueline M Mason, Dan Chi-Chia Lin, Xin Wei, et al.
Cancer Research|November 21, 2023
Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic LethalityPeter Lin, Corey Lourenco, Jennifer Cruickshank, et al.
Pageof 14